<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Clinical Validation and Prospective Deployment of an Automated Deep Learning-Based Coronary Segmentation and Cardiac Toxicity Risk Prediction System - Health AI Hub</title>
    <meta name="description" content="This paper presents the clinical validation and real-world deployment of an automated deep learning-based system for precise segmentation of cardiac substructur">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Clinical Validation and Prospective Deployment of an Automated Deep Learning-Based Coronary Segmentation and Cardiac Toxicity Risk Prediction System</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.14971v1" target="_blank">2511.14971v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-18
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Christian V. Guthier, Christopher E Kehayias, Cosmin Ciausu, Jordan O. Gasho, John He, Maria Oorloff, Samuel C. Zhang, Danielle S. Bitterman, Jeremy S. Bredfeldt, Kelly Fitzgerald, Benjamin H. Kann, David E. Kozono, Jennifer Steers, Marion Tonneau, Anju Nohria, Hugo J. W. L. Aerts, Katelyn M. Atkins, Raymond H. Mak
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> physics.med-ph
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.98 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.14971v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.14971v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper presents the clinical validation and real-world deployment of an automated deep learning-based system for precise segmentation of cardiac substructures from CT scans and subsequent prediction of cardiac toxicity risk. The AI system demonstrated high geometric accuracy and dose-volume concordance, successfully reproduced known dose-outcome relationships for cardiac events, and proved effective in large-scale retrospective analysis and prospective real-time surveillance for identifying high-risk patients.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This innovation offers a critical tool for clinicians to accurately and efficiently monitor cardiac radiation exposure in patients undergoing thoracic radiotherapy, enabling personalized treatment planning to mitigate long-term cardiac toxicity. It facilitates real-time risk assessment and early referral, ultimately improving patient safety and outcomes.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>An automated deep learning-based AI system for coronary segmentation from thoracic CT scans and subsequent prediction of cardiac toxicity risk due to radiation exposure. It performs real-time surveillance of cardiac dose, flags high-risk patients for potential cardiology referral, and can facilitate dose-sparing radiation therapy and follow-up.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>A 3D UNet deep learning model was developed for automated segmentation of cardiac substructures (heart, LAD) from thoracic CT scans, trained on 560 cases and validated internally (n=70) and externally (n=283).</li>
                    
                    <li>The system achieved high geometric accuracy with median Dice scores of 0.95 for the heart and 0.87 for the LAD, and low average surface distance errors (1.1 mm for heart, 1.9 mm for LAD).</li>
                    
                    <li>Dose-volume parameters showed strong concordance, with a median absolute difference of only 1% for LAD V15 (volume receiving 15 Gy) compared to manual segmentation.</li>
                    
                    <li>AI-derived LAD V15 was independently associated with Major Adverse Cardiac Events (MACE) (subdistribution HR, 1.03; 95% CI, 1.01-1.05) and All-Cause Mortality (ACM) (adjusted HR, 1.02; 95% CI, 1.00-1.03) in both internal and external validations.</li>
                    
                    <li>Retrospective deployment on 3,399 lung cancer patients revealed a 32% relative decline in median LAD V15 (from 12% to 8%) between 2014 and 2022, and identified 32% of patients receiving high-risk cardiac doses.</li>
                    
                    <li>Prospective surveillance on 1,386 contemporary patients successfully flagged 19% for potential cardiology referral, demonstrating its utility for real-time risk assessment and intervention at the point-of-care.</li>
                    
                    <li>The system provides a validated tool for large-scale cardiac dose monitoring and point-of-care alerts, supporting the adoption of coronary-sparing radiation therapy and enhanced patient follow-up.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study employed a retrospective and prospective design. A 3D UNet deep learning model was trained on 560 thoracic CT scans, with subsequent internal validation (n=70) and external validation (n=283) to assess geometric accuracy (Dice/ASSD) and concordance of dose-volume parameters (e.g., LAD V15). Clinical utility was established by correlating AI-derived substructure metrics with patient outcomes (MACE, ACM). The system was then implemented in two phases: retrospective analysis of 3,399 lung cancer patients to track dose trends and identify high-risk exposures, and prospective surveillance of 1,386 consecutive patients for real-time cardiac toxicity risk alerts.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The AI system achieved high segmentation accuracy for the heart (Dice 0.95, ASSD 1.1 mm) and LAD (Dice 0.87, ASSD 1.9 mm), with a median absolute difference of 1% in LAD V15 compared to manual methods. AI-derived LAD V15 was independently associated with MACE (HR 1.03) and ACM (HR 1.02). Retrospective analysis showed a 32% relative decline in median LAD V15 from 2014-2022 (12% to 8%) and identified 32% of lung cancer patients with high-risk cardiac doses. Prospective surveillance successfully flagged 19% of patients for potential cardiology referral based on cardiac dose exposure.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This automated AI system provides a validated, robust tool for clinicians to accurately quantify cardiac radiation dose, predict cardiac toxicity risk, and identify high-risk patients in real time. This capability can drive the adoption of more cardiac-sparing radiation therapy techniques, enable proactive management of radiation-induced cardiac complications, and facilitate timely cardiology referrals, ultimately leading to improved long-term quality of life and survival for cancer patients.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations of the study, such as specific dataset biases, generalizability to other cancer types, or computational resource requirements.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The authors conclude that automated cardiac dose monitoring can facilitate the broader adoption of coronary-sparing radiation therapy and improve follow-up strategies for patients at risk of cardiac toxicity, implying future research and implementation efforts in these areas.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Radiation Oncology</span>
                    
                    <span class="tag">Cardiology</span>
                    
                    <span class="tag">Medical Physics</span>
                    
                    <span class="tag">Oncology</span>
                    
                    <span class="tag">Diagnostic Radiology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Deep Learning</span>
                    
                    <span class="tag tag-keyword">Cardiac Segmentation</span>
                    
                    <span class="tag tag-keyword">Radiation Oncology</span>
                    
                    <span class="tag tag-keyword">Cardiac Toxicity</span>
                    
                    <span class="tag tag-keyword">LAD V15</span>
                    
                    <span class="tag tag-keyword">Lung Cancer</span>
                    
                    <span class="tag tag-keyword">Prospective Surveillance</span>
                    
                    <span class="tag tag-keyword">AI in Medicine</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Importance: Coronary algorithm for cardiac sub structures and prospective real-time surveillance of cardiac dose exposure. Methods: Retro and prospective study to validate AI auto-segmentation. A 3D UNet was trained on 560 thoracic CT scans from a single institution (2003-2014) and validated internally (n=70). External validation was performed in 283 patients treated at an independent institution (2005-2020). Clinical implementation comprised (1) retrospective analysis of 3,399 lung cancer patients treated in 2014-2022 and (2) prospective surveillance of 1,386 consecutive patients in 2023. Geometric accuracy, concordance of dose-volume parameters; association of AI-derived substructure metrics with outcome; temporal dose trends; and the proportion of patients exceeding prespecified risk. Results: Median (inter-quartile range) Dice/ASSD were 0.95 (0.94-0.96)/1.1 mm for the heart and 0.87 (0.82-0.90)/1.9 mm for the LAD; the median absolute difference between AI and manual LAD V15 was 1%. AI-derived LAD V15 remained independently associated with MACE (sub distribution hazard ratio [HR], 1.03%; 95% CI, 1.01-1.05) and ACM (adjusted HR, 1.02; 95% CI, 1.00-1.03), internally and externally. Retrospective deployment showed a 32% relative decline in median LAD V15 from 2014 to 2022 (12% to 8%) and identified high- risk doses in 1,086 of 3,399 patients (32%). Prospective surveillance flagged 264 contemporary patients (19%) for potential cardiology referral. Conclusions: A validated AI system accurately segments cardiac substructures, reproduces dose-outcome relationships, enables large-scale surveillance, and point-of-care alerts for high-risk patients. Automated cardiac dose monitoring could facilitate adoption of coronary-sparing therapy and follow-up.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>